ACTG2 and neoplasm: demonstrated that MUC16 deletion significantly impedes tumor progression and metastasis, leading to prolonged survival, and influences the tumor microenvironment, possibly by modulating the expression of genes like Actg2, Myh11, and Pdlim3 (112).